BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26837759)

  • 1. Activated KRAS Cooperates with MLL-AF4 to Promote Extramedullary Engraftment and Migration of Cord Blood CD34+ HSPC But Is Insufficient to Initiate Leukemia.
    Prieto C; Stam RW; Agraz-Doblas A; Ballerini P; Camos M; Castaño J; Marschalek R; Bursen A; Varela I; Bueno C; Menendez P
    Cancer Res; 2016 Apr; 76(8):2478-89. PubMed ID: 26837759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-independent FLT3 activation does not cooperate with MLL-AF4 to immortalize/transform cord blood CD34+ cells.
    Montes R; Ayllón V; Prieto C; Bursen A; Prelle C; Romero-Moya D; Real PJ; Navarro-Montero O; Chillón C; Marschalek R; Bueno C; Menendez P
    Leukemia; 2014 Mar; 28(3):666-74. PubMed ID: 24240202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enforced expression of MLL-AF4 fusion in cord blood CD34+ cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia.
    Montes R; Ayllón V; Gutierrez-Aranda I; Prat I; Hernández-Lamas MC; Ponce L; Bresolin S; Te Kronnie G; Greaves M; Bueno C; Menendez P
    Blood; 2011 May; 117(18):4746-58. PubMed ID: 21389315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs.
    Bueno C; Ayllón V; Montes R; Navarro-Montero O; Ramos-Mejia V; Real PJ; Romero-Moya D; Araúzo-Bravo MJ; Menendez P
    Blood; 2013 May; 121(19):3867-78, S1-3. PubMed ID: 23479570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between
    Bueno C; Calero-Nieto FJ; Wang X; Valdés-Mas R; Gutiérrez-Agüera F; Roca-Ho H; Ayllon V; Real PJ; Arambilet D; Espinosa L; Torres-Ruiz R; Agraz-Doblas A; Varela I; de Boer J; Bigas A; Gottgens B; Marschalek R; Menendez P
    Haematologica; 2019 Jun; 104(6):1189-1201. PubMed ID: 30679325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AF4-MLL fusion transiently augments multilineage hematopoietic engraftment but is not sufficient to initiate leukemia in cord blood CD34
    Prieto C; Marschalek R; Kühn A; Bursen A; Bueno C; Menéndez P
    Oncotarget; 2017 Oct; 8(47):81936-81941. PubMed ID: 29137234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair.
    Castaño J; Herrero AB; Bursen A; González F; Marschalek R; Gutiérrez NC; Menendez P
    Oncotarget; 2016 May; 7(21):30440-52. PubMed ID: 27119507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia.
    Sanjuan-Pla A; Bueno C; Prieto C; Acha P; Stam RW; Marschalek R; Menéndez P
    Blood; 2015 Dec; 126(25):2676-85. PubMed ID: 26463423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of MEK and ATR is effective in a B-cell acute lymphoblastic leukemia model driven by
    Chu SH; Song EJ; Chabon JR; Minehart J; Matovina CN; Makofske JL; Frank ES; Ross K; Koche RP; Feng Z; Xu H; Krivtsov A; Nussenzweig A; Armstrong SA
    Blood Adv; 2018 Oct; 2(19):2478-2490. PubMed ID: 30266823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis.
    Chang YI; You X; Kong G; Ranheim EA; Wang J; Du J; Liu Y; Zhou Y; Ryu MJ; Zhang J
    Leukemia; 2015 Sep; 29(9):1847-56. PubMed ID: 25801914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement.
    Bueno C; Montes R; Catalina P; Rodríguez R; Menendez P
    Leukemia; 2011 Mar; 25(3):400-10. PubMed ID: 21135858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal liver Mll-AF4+ hematopoietic stem and progenitor cells respond directly to poly(I:C), but not to a single maternal immune activation.
    Malouf C; Ottersbach K
    Exp Hematol; 2019 Aug; 76():49-59. PubMed ID: 31381950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis.
    Trentin L; Bresolin S; Giarin E; Bardini M; Serafin V; Accordi B; Fais F; Tenca C; De Lorenzo P; Valsecchi MG; Cazzaniga G; Kronnie GT; Basso G
    Sci Rep; 2016 Oct; 6():34449. PubMed ID: 27698462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRAS(G12V) enhances proliferation and initiates myelomonocytic differentiation in human stem/progenitor cells via intrinsic and extrinsic pathways.
    Fatrai S; van Gosliga D; Han L; Daenen SM; Vellenga E; Schuringa JJ
    J Biol Chem; 2011 Feb; 286(8):6061-70. PubMed ID: 21169357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The silent mutational landscape of infant MLL-AF4 pro-B acute lymphoblastic leukemia.
    Dobbins SE; Sherborne AL; Ma YP; Bardini M; Biondi A; Cazzaniga G; Lloyd A; Chubb D; Greaves MF; Houlston RS
    Genes Chromosomes Cancer; 2013 Oct; 52(10):954-60. PubMed ID: 23893660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of Gpr125 in the myeloid sarcoma formation induced by cooperating MLL/AF10(OM-LZ) and oncogenic KRAS in a mouse bone marrow transplantation model.
    Fu JF; Yen TH; Chen Y; Huang YJ; Hsu CL; Liang DC; Shih LY
    Int J Cancer; 2013 Oct; 133(8):1792-802. PubMed ID: 23564351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic transforming potential of activated ras in chimeric mice.
    Hawley RG; Fong AZ; Ngan BY; Hawley TS
    Oncogene; 1995 Sep; 11(6):1113-23. PubMed ID: 7566971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-lymphopoietic capacity of cord blood-derived CD34+ progenitor cells.
    Gardner JP; Rosenzweig M; Marks DF; Harper D; Gaynor K; Fallon RJ; Wall DA; Johnson RP; Scadden DT
    Exp Hematol; 1998 Sep; 26(10):991-9. PubMed ID: 9728935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of AC133 vs. CD34 in acute childhood leukemias].
    Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
    Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An AF9/ENL-targted peptide with therapeutic potential in mixed lineage leukemias.
    Barretto NN; Karahalios DS; You D; Hemenway CS
    J Exp Ther Oncol; 2014; 10(4):293-300. PubMed ID: 25509985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.